Clinical Outcomes Following a Switch from Remicade® to the Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: A Prospective Observational Cohort Study
Lisa Smits(Radboud University Nijmegen), Frank Hoentjen(Radboud University Nijmegen), Joost P.H. Drenth(Radboud University Nijmegen), Ronald S. Boshuizen(Sanquin), Aura A. J. van Esch(Radboud University Nijmegen), Dirk J. de Jong(Radboud University Nijmegen), Lauranne Derikx(Radboud University Nijmegen)
Cited by 140
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
|United European Gastroenterology Journal|2017|698
Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders
|Journal of Clinical Investigation|2007|362
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252